M.M. GADZHIKULIEVA¹, A.D. NIKITINA², E.V. TSYGANOVA³, N.A. TSVETKOVA⁴

 ¹Russian University of Medicine, Moscow

²Polyclinic No. 1 of the Administrative Office of the President of the Russian Federation, Moscow

³Moscow City Centre for AIDS Prevention and Treatment, Moscow

⁴Infectious Clinical Hospital No. 2, Moscow

Contact details:

Nikitina A.D. — infectious disease specialist

Address: 26/28 Sivtsev Vrazhek alley, 119002 Moscow, Russian Federation, tel.: +7-969-055-37-48, e-mail: evenorde@gmail.com

The purpose — to determine predictors of adverse outcome in patients with HIV infection and kidney damage.

Material and methods. A retrospective comparative study of 1,787 autopsy records from Infectious Clinical Hospital No. 2, Moscow (2021–2023) included epidemiological, clinical, and laboratory parameters of patients with confirmed HIV infection and renal involvement. The main group comprised 239 patients with confirmed renal involvement and fatal outcome. The comparison group included patients with established renal involvement without fatal outcome (n = 56). We assessed biochemical, hematological, immunological parameters, and systemic inflammation indices.

Results. Arterial hypertension was significantly more prevalent in the deceased group (57.3 vs. 23.2%; p < 0.001). The median CD4⁺ lymphocyte count in the deceased group was significantly lower: 35 [8; 103] vs. 162 [47; 311] cells/µL (p < 0.001). High viral load (HIV RNA >100,000 copies/mL) was also significantly more frequent in the deceased group — 87.9 vs. 53.6% (p < 0.001). The median serum albumin level in the deceased group was 26.0 [21.9; 31.9] vs. 36.3 [29.8; 41.9] g/L (p < 0.001). No statistically significant between-group differences in eGFR were detected (79.6 [37.5; 110.8] vs. 82.0 [39.5; 101.5] mL/min/1.73 m²; p = 0.895). The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII) were significantly higher in the deceased group compared to the non-fatal outcome group (p < 0.001; p = 0.008; p < 0.001, respectively). Multivariate analysis identified four independent predictors of fatal outcome: high HIV RNA viral load (aOR = 8.73; 95% CI 3.10–24.57; p < 0.001), decreased CD4⁺ lymphocyte count (each reduction of 10 cells/µL was associated with a 10.5% increase in the risk of fatal outcome) (aOR = 0.99; 95% CI 0.98–0.99; p < 0.001), arterial hypertension (aOR = 4.40; 95% CI 1.51–12.87; p = 0.007), and hypoalbuminemia (aOR = 0.90; 95% CI 0.85–0.94 per 1 g/L decrease; p < 0.001). The prognostic model demonstrated high discriminatory ability (AUC-ROC = 0.918; 95% CI 0.856–0.964; p < 0.001).

Conclusion. Independent predictors of adverse outcomes in patients with HIV infection and renal involvement are high viremia, profound immunosuppression, hypoalbuminemia, and arterial hypertension. The findings highlight the importance of timely initiation of antiretroviral therapy, management of arterial hypertension, and regular monitoring of nutritional status in HIV patients with renal involvement to reduce the risk of adverse outcomes.

Key words: HIV infection, kidney damage, predictors of fatal outcome, viral load, CD4⁺ lymphocytes

 REFERENCES

1. Bekker L.G., Beyrer C., Mgodi N. et al. HIV infection. Nat Rev Dis Primers, 2023, vol. 9, p. 42. DOI 10.1038/s41572-023-00452-3
2. Mody A., Sohn A.H., Iwuji C. et al. HIV epidemiology, prevention, treatment, and implementation strategies for public health. Lancet, 2024, vol. 403 (10425), pp. 471–492.
3. Swanepoel C.R., Atta M.G., D’Agati V.D. et al. Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int, 2018, vol. 93 (3), pp. 545–559.
4. Palau L., Menez S., Rodriguez-Sanchez J. et al. HIV-associated nephropathy: links, risks and management. HIV AIDS (Auckl), 2018, vol. 10, pp. 73–81. DOI: 10.2147/HIV.S141978
5. Diana N.E., Naicker S. The changing landscape of HIV-associated kidney disease. Nat. Rev. Nephrol, 2024, vol. 20, pp. 330–346. DOI: 10.1038/s41581-023-00801-1
6. Abate M.D., Wagnew F., Getnet M. et al. Incidence, progression and predictors of chronic kidney disease among people living with HIV/AIDS on antiretroviral therapy in Ethiopia. BMJ Open, 2025, vol. 15, p. e090764. DOI: 10.1136/bmjopen-2024-090764
7. Althoff K.N., Stewart C., Humes E. et al. The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: a modeling study. PLoS Med, 2024, vol. 21, p. e1004325. DOI: 10.1371/journal.pmed.1004325
8. Khoza S.P., Prakaschandra D.R., Naidoo D.P. et al. The effect of HIV infection on glycaemia and renal function in type 2 diabetic subjects: a comparative cross-sectional study. PLoS One, 2018, vol. 13 (6), p. e0199946. DOI: 10.1371/journal.pone.0199946
9. Kalayjian R.C., Franceschini N., Gupta S.K. et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS, 2012, vol. 26 (15), pp. 1907–1915. DOI: 10.1097/QAD.0b013e328357f5ed
10. Gao H., Zhang R., Liu Y. et al. The incidence and dynamic risk factors of chronic kidney disease among people with HIV: a real-world cohort study. J. Infect, 2023, vol. 87 (4), pp. 298–307. DOI: 10.1016/j.jinf.2023.07.012
11. Gadzhikuliyeva M.M., Nikitina A.D., Tsyganova E.V., Tsvetkova N.A. Analysis of predictors of kidney damage development in patients with HIV infection. Prakticheskaya meditsina, 2025, vol. 23, no. 6, pp. 96–102 (in Russ.).
12. Croxford S., Kitching A., Desai S. et al. Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort. Lancet Public Health, 2017, vol. 2 (1), pp. e35–e46. DOI: 10.1016/S2468-2667(16)30020-2
13. McCutcheon K., Nqebelele U., Murray L. et al. Cardiac and renal comorbidities in aging people living with HIV. Circ. Res, 2024, vol. 134 (11), pp. 1636–1660. DOI 10.1161/CIRCRESAHA.124.323948
14. Heron J.E., Bagnis C.I., Gracey D.M. Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV. AIDS Res. Ther, 2020, vol. 17, p. 11. DOI: 10.1186/s12981-020-00266-3
15. Okpa H.O., Bisong E.M., Enang O.E. et al. Predictors of chronic kidney disease among HIV-infected patients on highly active antiretroviral therapy at the University of Calabar Teaching Hospital, Nigeria. HIV AIDS (Auckl), 2019, vol. 11, pp. 61–67. DOI: 10.2147/HIV.S189802
16. Eshetu B., Daba C., Shibiru S. et al. Prevalence of chronic kidney diseases among people living with HIV in Ethiopia: a systematic review and meta-analysis. BMC Infectious Diseases, 2025, vol. 25, p. 82. DOI: 10.1186/s12879-024-10319-5
17. Chazova I.E., Kislyak O.A., Podzolkov V.I. et al. Arterial hypertension and chronic kidney disease: consensus statement on patient management. Syst. Hypertens, 2023, vol. 20 (1), pp. 5–19.
18. Ou-Yang H., Fu H.Y., Luo Y. et al. Inflammation markers and the risk of hypertension in people living with HIV. Front. Immunol, 2023, vol. 14, p. 1133640. DOI: 10.3389/fimmu.2023.1133640
19. Fisher M.C., Wyatt C.M., Estrella M.M. HIV-associated kidney diseases: progress, gaps, and future directions. Clin. Microbiol. Rev, 2025, pp. e00207-25. DOI 10.1128/cmr.00207-25
20. Ahmed A.A., Hassan H.A., Mswelo V.E. et al. Hypoalbuminemia in HIV-infected patients: its determinants and correlation with CD4⁺ count in Northern Uganda. AIDS Res. Ther, 2025, vol. 22 (1), p. 88. DOI: 10.1186/s12981-025-00757-1
21. Ndlovu K.C.Z., Chikobvu P., Mofokeng T. et al. Serum albumin and mortality in patients with HIV and end-stage renal failure on peritoneal dialysis. PLoS One, 2019, vol. 14 (6), p. e0218156. DOI: 10.1371/journal.pone.0218156
22. Li L., Chen K., Wen C. et al. Association between systemic immune-inflammation index and chronic kidney disease: a population-based study. PLoS One, 2024, vol. 19 (2), p. e0292646. DOI: 10.1371/journal.pone.0292646
23. Zhao T., Wang X., Song Y. et al. Association between the systemic immune-inflammation index and 24-week outcomes in patients with HIV-associated cryptococcal meningitis: secondary analysis of a prospective multicenter cohort study. J. Inflamm. Res, 2025, vol. 18, pp. 16991–17003. DOI: 10.2147/JIR.S555540
24. Guo F., Chen J., Zhang H. Predictive value of neutrophil to lymphocyte ratio for the clinical outcomes of acquired immune deficiency syndrome: a systematic review and meta-analysis. Front. Med, 2025, vol. 12, pp. 1503614. DOI 10.3389/fmed.2025.1503614
25. Raffetti E., Donato F., Casari S. et al. Systemic inflammation-based scores and mortality for all causes in HIV-infected patients: a MASTER cohort study. BMC Infect. Dis, 2017, vol. 17 (1), p. 193. DOI: 10.1186/s12879-017-2280-5
26. Wang C.X., Letendre S.L., Hong S. et al. Differential systemic immune-inflammation index levels in people with and without HIV infection. AIDS, 2025, vol. 39 (5), pp. 554–559. DOI 10.1097/QAD.0000000000004088